These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1708404)

  • 1. Effects of L-deprenyl and amantadine in an MPTP-model of parkinsonism.
    Rausch WD; Schallauer E; Chan WW; Riederer P; Weiser M
    J Neural Transm Suppl; 1990; 32():269-75. PubMed ID: 1708404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amantadine enhances dopamine and serotonin turnover in the MPTP model of Parkinson's disease.
    Altagracia M; Rojas P; Kravzov J; Rios C
    Proc West Pharmacol Soc; 1993; 36():289-91. PubMed ID: 7690973
    [No Abstract]   [Full Text] [Related]  

  • 3. Neurochemical changes in the substantiae nigrae and caudate nuclei following acute unilateral intranigral infusions of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Sirinathsinghji DJ; Whittington PE; Audsley AR
    Brain Res; 1986 Dec; 399(2):339-45. PubMed ID: 2435361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of deprenyl on monoamine oxidase and neurotransmitters in the brains of MPTP-treated aging mice.
    Gupta M; Wiener HL
    Neurochem Res; 1995 Apr; 20(4):385-9. PubMed ID: 7544444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pargyline and deprenyl prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in monkeys.
    Cohen G; Pasik P; Cohen B; Leist A; Mytilineou C; Yahr MD
    Eur J Pharmacol; 1984 Oct; 106(1):209-10. PubMed ID: 6442232
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic L-deprenyl does not alter the restoration of striatal dopamine in MPTP-lesioned mice.
    Wiener HL; Hashim A; Lajtha A; Sershen H
    J Neurosci Res; 1989 Jul; 23(3):326-9. PubMed ID: 2504936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A high dose of MPTP overcomes the protective effect of selegiline against dopaminergic neurotoxicity.
    Fuller RW; Hemrick-Luecke SK
    J Pharm Pharmacol; 1989 Jul; 41(7):492-3. PubMed ID: 2570859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of L-deprenyl on MPP+- and MPTP-induced dopamine overflow in microdialysates of striatum and nucleus accumbens.
    Wu WR; Zhu ZT; Zhu XZ
    Life Sci; 2000 Jun; 67(3):241-50. PubMed ID: 10983868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased caudate dopamine turnover may contribute to the recovery of motor function in marmosets treated with the dopaminergic neurotoxin MPTP.
    Rose S; Nomoto M; Kelly E; Kilpatrick G; Jenner P; Marsden CD
    Neurosci Lett; 1989 Jul; 101(3):305-10. PubMed ID: 2505199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MPTP-induced parkinsonism in primates: pattern of striatal dopamine loss following acute and chronic administration.
    Pérez-Otaño I; Oset C; Luquin MR; Herrero MT; Obeso JA; Del Río J
    Neurosci Lett; 1994 Jul; 175(1-2):121-5. PubMed ID: 7970192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nimodipine on the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced depletions in the biogenic amine levels in mice.
    Gerlach M; Russ H; Winker J; Witzmann K; Traber J; Stasch JP; Riederer P; Przuntek H
    Arzneimittelforschung; 1993 Apr; 43(4):413-5. PubMed ID: 7684224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium diethyldithiocarbamate protects against the MPTP-induced inhibition of immune responses in mice.
    Renoux G; Bizière K; Renoux M; Steinberg R; Kan JP; Guillaumin JM
    Life Sci; 1989; 44(12):771-7. PubMed ID: 2539542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the levels of dopamine, serotonin and their metabolites in the caudate nucleus of the rat.
    Russ H; Henning K; Eckhardt H; Przuntek H
    Arzneimittelforschung; 1985; 35(2):481-2. PubMed ID: 2581589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partially protective effect of amantadine in the MPTP model of Parkinson's disease.
    Rojas P; Altagracia M; Kravsov J; Rios C
    Proc West Pharmacol Soc; 1992; 35():33-5. PubMed ID: 1502234
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of bifemelane on parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset.
    Nomoto M; Irifune M; Fukuzaki K; Fukuda T
    Neurosci Lett; 1994 Aug; 178(1):95-8. PubMed ID: 7816348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice is enhanced by ethanol or acetaldehyde.
    Corsini GU; Zuddas A; Bonuccelli U; Schinelli S; Kopin IJ
    Life Sci; 1987 Mar; 40(9):827-32. PubMed ID: 2434820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neurotoxic actions of 1-methyl-4-phenylpyridine (MPP+) are not prevented by deprenyl treatment.
    Bradbury AJ; Costall B; Jenner PG; Kelly ME; Marsden CD; Naylor RJ
    Neurosci Lett; 1985 Jul; 58(2):177-81. PubMed ID: 2413398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MPTP-induced parkinsonism: acceleration of biochemical and behavioral recovery by GM1 ganglioside treatment.
    Schneider JS
    J Neurosci Res; 1992 Jan; 31(1):112-9. PubMed ID: 1613817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of substituted amphetamines (PMA, MDMA, and METH) on monoamines in rat caudate: a microdialysis study.
    Gough B; Imam SZ; Blough B; Slikker W; Ali SF
    Ann N Y Acad Sci; 2002 Jun; 965():410-20. PubMed ID: 12105116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral and biochemical changes following acute administration of MPTP and MPP+.
    Tadano T; Satoh N; Sakuma I; Matsumura T; Kisara K; Arai Y; Kinemuchi H
    Life Sci; 1987 Mar; 40(13):1309-18. PubMed ID: 2436017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.